Blaine Doyle

Bio

Blaine Doyle has been awarded a PandemicTech Innovation Fellowship for 2020 to continue scaling his company, GlowDx, and its testing efforts across Latin America in the battle against COVID-19. Currently GlowDx is focused on adapting their home testing model to COVID-19, enabling people to get access to testing for COVID-19 while sheltering in place. This will also take significant pressure off of healthcare centres by reducing patient traffic and reducing nosocomial transmission of COVID-19.

PandemicTech is a community of innovators based in Austin, Texas, dedicated to fighting pandemic infectious disease threats by bridging the gap between the infectious disease community and technology. “With the support of this fellowship, we aim to increase test availability within the region and subdue this health crisis,” declared CEO, Blaine Doyle. “We are excited to be a part of this exciting network of innovators who are seeking to tackle COVID-19 and future health threats with novel technologies.”

GlowDx will have access to a platform for those on the front lines of the fight against pandemics and will receive strategic support from international partners. PandemicTech is an expertise-based innovation ecosystem that advances global health security through the armory of ideas and action. Through the virtual incubator, innovators receive customized financial, business and product-related resources to grow and scale their ideas in collaboration with the PandemicTech network of global partners.

Blaine is a molecular biologist turned entrepreneur focused on democratising access to diagnostics in emerging markets. He is an alum of Biotechnology DCU & Molecular Cell Biology with Bioinnovation UCC. He also considers himself an alum of IndieBio, Séan O’Sullivan’s Biotech Accelerator, which he states “changed my perception of the world and technologies place in our future.” Blaine is a board member of the Irish Mexican Chamber, bridging business from Ireland to Latin America.